Changes in the vaccine advisory process in the United States have disrupted immunization guidance, which reinforces the need for independent evidence review to inform decisions regarding immunization ...
Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...
The 2024-2025 COVID-19 and influenza vaccines provided protection against ED/UC, outpatient visits, and hospitalizations. In the 2024-2025 season, the COVID-19 vaccine provided additional protection ...
The landscape of COVID-19 prevention continues to evolve, with three distinct vaccine options now available for the 2024-2025 season. These updated formulations represent a significant advancement in ...
Although most Americans have eschewed seasonal COVID-19 vaccines, the updated shots continue to show significant protection against cardiovascular disease, especially for those over age 75 and those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results